Phyto Partners is a venture capital firm that provides debt and equity capital to privately held cannabis companies, focusing on ancillary businesses critical to the industry's growth. The firm also invests in neurowellness, brain health, and psychedelic medicine.
Average disclosed round size is $14.5M (across 11 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| IInteraxon | Series C | $9.5M | Aug 2022 |
| MMuse by Interaxon | Series C | $9.5M | Jan 2022 |
 Fyllo | Series C | $40M | Nov 2021 |
 LeafLink | Series C | $40M | Dec 2020 |
| Fyllo | Series A | $10M | Aug 2020 |
 Flowhub | Series A | $23M | Oct 2019 |
| FFront Range Biosciences | Unknown | $8.5M | Sep 2019 |
| LLucid Green | Series A | — | Nov 2018 |
| FFront Range Biosciences | Series A | $10M | Oct 2018 |
 Wurk | Bridge | $3.2M | Apr 2018 |
| Wurk | Bridge | $3.2M | Jan 2018 |
| LeafLink | Seed | $3M | Jan 2017 |
Top Co-Investors
Altitude Investment Management4 shared
Poseidon Asset Management3 shared
Leo Capital2 shared
JW Asset Management2 shared
Sand Hill Angels2 shared
Export Development Canada2 shared
BDC Capital2 shared
Alabaster2 shared
Casa Verde Capital2 shared
Founders Fund2 shared
Lerer Hippeau2 shared
India Quotient1 shared
K2 Global1 shared
SOL Global Investments Corp.1 shared
ArrowMark Partners1 shared
Ardian1 shared
ff Venture Capital1 shared
Felicis1 shared
Grok Ventures1 shared
Nosara Capital1 shared
Last updated: 7 October 2026